Oncolytic HSV-1 Promising in Refractory Incurable Non-CNS Solid Tumors in Pediatric Patients
Oncolytic variants of the HSV-1 have successfully treated melanoma, glioma, and other cancers in adults; in this study, researchers test the effectiveness of an oncolytic HSV-1 in pediatric patients.
